Caprock Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Sell
6,565
-2,115
-24% -$446K 0.03% 482
2025
Q4
$1.72M Buy
8,680
+638
+8% +$129K 0.04% 427
2025
Q3
$1.48M Buy
+8,042
New +$1.43M 0.04% 435
2025
Q1
$619K Buy
4,602
+938
+26% +$124K 0.02% 633
2024
Q4
$463K Sell
3,664
-258
-7% -$38.4K 0.02% 648
2024
Q3
$652K Buy
3,922
+337
+9% +$51K 0.02% 501
2024
Q2
$477K Buy
+3,585
New +$432K 0.02% 546
2022
Q2
Sell
-2,890
Closed -$248K 630
2022
Q1
$248K Hold
2,890
0.02% 493
2021
Q4
$236K Buy
+2,890
New +$211K 0.02% 506

Other funds holding THC

Caprock Group's THC Position: Q1 2026 in Review

Caprock Group reduced its Tenet Healthcare (THC) stake by 24% in Q1 2026, selling an estimated $446K and leaving 6,565 shares worth $1.24M. The position accounts for 0.03% of the portfolio, ranked #482.

Caprock Group first reported a position in THC in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.72M in Q4 2025. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Caprock Group held 6,565 shares of Tenet Healthcare worth $1.24M as of Q1 2026.
  • Caprock Group sold 2,115 Tenet Healthcare shares in Q1 2026, an estimated $446K.
  • Tenet Healthcare made up 0.03% of Caprock Group's portfolio in Q1 2026, its #482 holding.
  • Caprock Group first reported a position in Tenet Healthcare in Q4 2021 and has held it in 9 quarters since.
  • Caprock Group's Tenet Healthcare position peaked at $1.72M in Q4 2025.
  • 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.